Loading...
Images of Mayra Carneiro
(0 from 0 )News
Surface Oncology to Present Preclinical Data for Lead
www.globenewswire.com
10 Mar — Lead Authors: Devapregasan Moodley, Ph.D. and Mayra Carneiro. Summary: SRF617 is a potent inhibitor of CD39 enzymatic activity both in vitro ... › › Surfac...
Surface Oncology (SURF) Presents Promising Preclinical ...
www.streetinsider.com
9 Apr — ... cells and induces proinflammatory states in the CT26 syngeneic tumor modelLead Authors: Devapregasan Moodley, Ph.D. and Mayra Carneiro. › Corporate+News › Surf...
Surface Oncology Presents Promising Preclinical Data for ...
investors.surfaceoncology.com
9 Apr — Lead Authors: Devapregasan Moodley, Ph.D. and Mayra Carneiro. Summary: SRF617 is a potent inhibitor of CD39 enzymatic activity both in vitro ... › news-releases
Aniversário de 1 aninho João Victor - Frisson Online
www.frissononline.com.br
Agora somos Frisson Online, sob o comando da empresária Gaída Dias
sorted by relevance / date